Global AAV Vector Gene Therapy Supply, Demand and Key Producers, 2023-2029
The global AAV Vector Gene Therapy market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
AAV (Adeno-Associated Virus) vector gene therapy is a gene therapy method that uses adeno-associated virus as a vector to deliver, express or repair specific genes in patients. AAV is a non-pathogenic, non-oncogenic virus that is widely used in gene therapy research and clinical trials.
This report studies the global AAV Vector Gene Therapy production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for AAV Vector Gene Therapy, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of AAV Vector Gene Therapy that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global AAV Vector Gene Therapy total production and demand, 2018-2029, (K Units)
Global AAV Vector Gene Therapy total production value, 2018-2029, (USD Million)
Global AAV Vector Gene Therapy production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global AAV Vector Gene Therapy consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: AAV Vector Gene Therapy domestic production, consumption, key domestic manufacturers and share
Global AAV Vector Gene Therapy production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global AAV Vector Gene Therapy production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global AAV Vector Gene Therapy production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global AAV Vector Gene Therapy market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include uniQure, Roche, Novartis, BioMarin Pharmaceutical, Ferring Pharmaceuticals A/S, CSL Behring LLC, PTC Therapeutics, Inc. and Pfizer Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World AAV Vector Gene Therapy market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global AAV Vector Gene Therapy Market, By Region:
1. How big is the global AAV Vector Gene Therapy market?
2. What is the demand of the global AAV Vector Gene Therapy market?
3. What is the year over year growth of the global AAV Vector Gene Therapy market?
4. What is the production and production value of the global AAV Vector Gene Therapy market?
5. Who are the key producers in the global AAV Vector Gene Therapy market?
AAV (Adeno-Associated Virus) vector gene therapy is a gene therapy method that uses adeno-associated virus as a vector to deliver, express or repair specific genes in patients. AAV is a non-pathogenic, non-oncogenic virus that is widely used in gene therapy research and clinical trials.
This report studies the global AAV Vector Gene Therapy production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for AAV Vector Gene Therapy, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of AAV Vector Gene Therapy that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global AAV Vector Gene Therapy total production and demand, 2018-2029, (K Units)
Global AAV Vector Gene Therapy total production value, 2018-2029, (USD Million)
Global AAV Vector Gene Therapy production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global AAV Vector Gene Therapy consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: AAV Vector Gene Therapy domestic production, consumption, key domestic manufacturers and share
Global AAV Vector Gene Therapy production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global AAV Vector Gene Therapy production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global AAV Vector Gene Therapy production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global AAV Vector Gene Therapy market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include uniQure, Roche, Novartis, BioMarin Pharmaceutical, Ferring Pharmaceuticals A/S, CSL Behring LLC, PTC Therapeutics, Inc. and Pfizer Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World AAV Vector Gene Therapy market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global AAV Vector Gene Therapy Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- AAV1
- AAV2
- AAV8
- Other
- Duchenne Dystrophy
- Hemophilia
- Retinal Diseases
- Other
- uniQure
- Roche
- Novartis
- BioMarin Pharmaceutical
- Ferring Pharmaceuticals A/S
- CSL Behring LLC
- PTC Therapeutics, Inc.
- Pfizer Inc.
1. How big is the global AAV Vector Gene Therapy market?
2. What is the demand of the global AAV Vector Gene Therapy market?
3. What is the year over year growth of the global AAV Vector Gene Therapy market?
4. What is the production and production value of the global AAV Vector Gene Therapy market?
5. Who are the key producers in the global AAV Vector Gene Therapy market?
1 SUPPLY SUMMARY
1.1 AAV Vector Gene Therapy Introduction
1.2 World AAV Vector Gene Therapy Supply & Forecast
1.2.1 World AAV Vector Gene Therapy Production Value (2018 & 2022 & 2029)
1.2.2 World AAV Vector Gene Therapy Production (2018-2029)
1.2.3 World AAV Vector Gene Therapy Pricing Trends (2018-2029)
1.3 World AAV Vector Gene Therapy Production by Region (Based on Production Site)
1.3.1 World AAV Vector Gene Therapy Production Value by Region (2018-2029)
1.3.2 World AAV Vector Gene Therapy Production by Region (2018-2029)
1.3.3 World AAV Vector Gene Therapy Average Price by Region (2018-2029)
1.3.4 North America AAV Vector Gene Therapy Production (2018-2029)
1.3.5 Europe AAV Vector Gene Therapy Production (2018-2029)
1.3.6 China AAV Vector Gene Therapy Production (2018-2029)
1.3.7 Japan AAV Vector Gene Therapy Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 AAV Vector Gene Therapy Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 AAV Vector Gene Therapy Major Market Trends
2 DEMAND SUMMARY
2.1 World AAV Vector Gene Therapy Demand (2018-2029)
2.2 World AAV Vector Gene Therapy Consumption by Region
2.2.1 World AAV Vector Gene Therapy Consumption by Region (2018-2023)
2.2.2 World AAV Vector Gene Therapy Consumption Forecast by Region (2024-2029)
2.3 United States AAV Vector Gene Therapy Consumption (2018-2029)
2.4 China AAV Vector Gene Therapy Consumption (2018-2029)
2.5 Europe AAV Vector Gene Therapy Consumption (2018-2029)
2.6 Japan AAV Vector Gene Therapy Consumption (2018-2029)
2.7 South Korea AAV Vector Gene Therapy Consumption (2018-2029)
2.8 ASEAN AAV Vector Gene Therapy Consumption (2018-2029)
2.9 India AAV Vector Gene Therapy Consumption (2018-2029)
3 WORLD AAV VECTOR GENE THERAPY MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World AAV Vector Gene Therapy Production Value by Manufacturer (2018-2023)
3.2 World AAV Vector Gene Therapy Production by Manufacturer (2018-2023)
3.3 World AAV Vector Gene Therapy Average Price by Manufacturer (2018-2023)
3.4 AAV Vector Gene Therapy Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global AAV Vector Gene Therapy Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for AAV Vector Gene Therapy in 2022
3.5.3 Global Concentration Ratios (CR8) for AAV Vector Gene Therapy in 2022
3.6 AAV Vector Gene Therapy Market: Overall Company Footprint Analysis
3.6.1 AAV Vector Gene Therapy Market: Region Footprint
3.6.2 AAV Vector Gene Therapy Market: Company Product Type Footprint
3.6.3 AAV Vector Gene Therapy Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: AAV Vector Gene Therapy Production Value Comparison
4.1.1 United States VS China: AAV Vector Gene Therapy Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: AAV Vector Gene Therapy Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: AAV Vector Gene Therapy Production Comparison
4.2.1 United States VS China: AAV Vector Gene Therapy Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: AAV Vector Gene Therapy Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: AAV Vector Gene Therapy Consumption Comparison
4.3.1 United States VS China: AAV Vector Gene Therapy Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: AAV Vector Gene Therapy Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based AAV Vector Gene Therapy Manufacturers and Market Share, 2018-2023
4.4.1 United States Based AAV Vector Gene Therapy Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers AAV Vector Gene Therapy Production Value (2018-2023)
4.4.3 United States Based Manufacturers AAV Vector Gene Therapy Production (2018-2023)
4.5 China Based AAV Vector Gene Therapy Manufacturers and Market Share
4.5.1 China Based AAV Vector Gene Therapy Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers AAV Vector Gene Therapy Production Value (2018-2023)
4.5.3 China Based Manufacturers AAV Vector Gene Therapy Production (2018-2023)
4.6 Rest of World Based AAV Vector Gene Therapy Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based AAV Vector Gene Therapy Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers AAV Vector Gene Therapy Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers AAV Vector Gene Therapy Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World AAV Vector Gene Therapy Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 AAV1
5.2.2 AAV2
5.2.3 AAV8
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World AAV Vector Gene Therapy Production by Type (2018-2029)
5.3.2 World AAV Vector Gene Therapy Production Value by Type (2018-2029)
5.3.3 World AAV Vector Gene Therapy Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World AAV Vector Gene Therapy Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Duchenne Dystrophy
6.2.2 Hemophilia
6.2.3 Retinal Diseases
6.2.4 Other
6.3 Market Segment by Application
6.3.1 World AAV Vector Gene Therapy Production by Application (2018-2029)
6.3.2 World AAV Vector Gene Therapy Production Value by Application (2018-2029)
6.3.3 World AAV Vector Gene Therapy Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 uniQure
7.1.1 uniQure Details
7.1.2 uniQure Major Business
7.1.3 uniQure AAV Vector Gene Therapy Product and Services
7.1.4 uniQure AAV Vector Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 uniQure Recent Developments/Updates
7.1.6 uniQure Competitive Strengths & Weaknesses
7.2 Roche
7.2.1 Roche Details
7.2.2 Roche Major Business
7.2.3 Roche AAV Vector Gene Therapy Product and Services
7.2.4 Roche AAV Vector Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Roche Recent Developments/Updates
7.2.6 Roche Competitive Strengths & Weaknesses
7.3 Novartis
7.3.1 Novartis Details
7.3.2 Novartis Major Business
7.3.3 Novartis AAV Vector Gene Therapy Product and Services
7.3.4 Novartis AAV Vector Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Novartis Recent Developments/Updates
7.3.6 Novartis Competitive Strengths & Weaknesses
7.4 BioMarin Pharmaceutical
7.4.1 BioMarin Pharmaceutical Details
7.4.2 BioMarin Pharmaceutical Major Business
7.4.3 BioMarin Pharmaceutical AAV Vector Gene Therapy Product and Services
7.4.4 BioMarin Pharmaceutical AAV Vector Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 BioMarin Pharmaceutical Recent Developments/Updates
7.4.6 BioMarin Pharmaceutical Competitive Strengths & Weaknesses
7.5 Ferring Pharmaceuticals A/S
7.5.1 Ferring Pharmaceuticals A/S Details
7.5.2 Ferring Pharmaceuticals A/S Major Business
7.5.3 Ferring Pharmaceuticals A/S AAV Vector Gene Therapy Product and Services
7.5.4 Ferring Pharmaceuticals A/S AAV Vector Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Ferring Pharmaceuticals A/S Recent Developments/Updates
7.5.6 Ferring Pharmaceuticals A/S Competitive Strengths & Weaknesses
7.6 CSL Behring LLC
7.6.1 CSL Behring LLC Details
7.6.2 CSL Behring LLC Major Business
7.6.3 CSL Behring LLC AAV Vector Gene Therapy Product and Services
7.6.4 CSL Behring LLC AAV Vector Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 CSL Behring LLC Recent Developments/Updates
7.6.6 CSL Behring LLC Competitive Strengths & Weaknesses
7.7 PTC Therapeutics, Inc.
7.7.1 PTC Therapeutics, Inc. Details
7.7.2 PTC Therapeutics, Inc. Major Business
7.7.3 PTC Therapeutics, Inc. AAV Vector Gene Therapy Product and Services
7.7.4 PTC Therapeutics, Inc. AAV Vector Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 PTC Therapeutics, Inc. Recent Developments/Updates
7.7.6 PTC Therapeutics, Inc. Competitive Strengths & Weaknesses
7.8 Pfizer Inc.
7.8.1 Pfizer Inc. Details
7.8.2 Pfizer Inc. Major Business
7.8.3 Pfizer Inc. AAV Vector Gene Therapy Product and Services
7.8.4 Pfizer Inc. AAV Vector Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Pfizer Inc. Recent Developments/Updates
7.8.6 Pfizer Inc. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 AAV Vector Gene Therapy Industry Chain
8.2 AAV Vector Gene Therapy Upstream Analysis
8.2.1 AAV Vector Gene Therapy Core Raw Materials
8.2.2 Main Manufacturers of AAV Vector Gene Therapy Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 AAV Vector Gene Therapy Production Mode
8.6 AAV Vector Gene Therapy Procurement Model
8.7 AAV Vector Gene Therapy Industry Sales Model and Sales Channels
8.7.1 AAV Vector Gene Therapy Sales Model
8.7.2 AAV Vector Gene Therapy Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 AAV Vector Gene Therapy Introduction
1.2 World AAV Vector Gene Therapy Supply & Forecast
1.2.1 World AAV Vector Gene Therapy Production Value (2018 & 2022 & 2029)
1.2.2 World AAV Vector Gene Therapy Production (2018-2029)
1.2.3 World AAV Vector Gene Therapy Pricing Trends (2018-2029)
1.3 World AAV Vector Gene Therapy Production by Region (Based on Production Site)
1.3.1 World AAV Vector Gene Therapy Production Value by Region (2018-2029)
1.3.2 World AAV Vector Gene Therapy Production by Region (2018-2029)
1.3.3 World AAV Vector Gene Therapy Average Price by Region (2018-2029)
1.3.4 North America AAV Vector Gene Therapy Production (2018-2029)
1.3.5 Europe AAV Vector Gene Therapy Production (2018-2029)
1.3.6 China AAV Vector Gene Therapy Production (2018-2029)
1.3.7 Japan AAV Vector Gene Therapy Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 AAV Vector Gene Therapy Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 AAV Vector Gene Therapy Major Market Trends
2 DEMAND SUMMARY
2.1 World AAV Vector Gene Therapy Demand (2018-2029)
2.2 World AAV Vector Gene Therapy Consumption by Region
2.2.1 World AAV Vector Gene Therapy Consumption by Region (2018-2023)
2.2.2 World AAV Vector Gene Therapy Consumption Forecast by Region (2024-2029)
2.3 United States AAV Vector Gene Therapy Consumption (2018-2029)
2.4 China AAV Vector Gene Therapy Consumption (2018-2029)
2.5 Europe AAV Vector Gene Therapy Consumption (2018-2029)
2.6 Japan AAV Vector Gene Therapy Consumption (2018-2029)
2.7 South Korea AAV Vector Gene Therapy Consumption (2018-2029)
2.8 ASEAN AAV Vector Gene Therapy Consumption (2018-2029)
2.9 India AAV Vector Gene Therapy Consumption (2018-2029)
3 WORLD AAV VECTOR GENE THERAPY MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World AAV Vector Gene Therapy Production Value by Manufacturer (2018-2023)
3.2 World AAV Vector Gene Therapy Production by Manufacturer (2018-2023)
3.3 World AAV Vector Gene Therapy Average Price by Manufacturer (2018-2023)
3.4 AAV Vector Gene Therapy Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global AAV Vector Gene Therapy Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for AAV Vector Gene Therapy in 2022
3.5.3 Global Concentration Ratios (CR8) for AAV Vector Gene Therapy in 2022
3.6 AAV Vector Gene Therapy Market: Overall Company Footprint Analysis
3.6.1 AAV Vector Gene Therapy Market: Region Footprint
3.6.2 AAV Vector Gene Therapy Market: Company Product Type Footprint
3.6.3 AAV Vector Gene Therapy Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: AAV Vector Gene Therapy Production Value Comparison
4.1.1 United States VS China: AAV Vector Gene Therapy Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: AAV Vector Gene Therapy Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: AAV Vector Gene Therapy Production Comparison
4.2.1 United States VS China: AAV Vector Gene Therapy Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: AAV Vector Gene Therapy Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: AAV Vector Gene Therapy Consumption Comparison
4.3.1 United States VS China: AAV Vector Gene Therapy Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: AAV Vector Gene Therapy Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based AAV Vector Gene Therapy Manufacturers and Market Share, 2018-2023
4.4.1 United States Based AAV Vector Gene Therapy Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers AAV Vector Gene Therapy Production Value (2018-2023)
4.4.3 United States Based Manufacturers AAV Vector Gene Therapy Production (2018-2023)
4.5 China Based AAV Vector Gene Therapy Manufacturers and Market Share
4.5.1 China Based AAV Vector Gene Therapy Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers AAV Vector Gene Therapy Production Value (2018-2023)
4.5.3 China Based Manufacturers AAV Vector Gene Therapy Production (2018-2023)
4.6 Rest of World Based AAV Vector Gene Therapy Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based AAV Vector Gene Therapy Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers AAV Vector Gene Therapy Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers AAV Vector Gene Therapy Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World AAV Vector Gene Therapy Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 AAV1
5.2.2 AAV2
5.2.3 AAV8
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World AAV Vector Gene Therapy Production by Type (2018-2029)
5.3.2 World AAV Vector Gene Therapy Production Value by Type (2018-2029)
5.3.3 World AAV Vector Gene Therapy Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World AAV Vector Gene Therapy Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Duchenne Dystrophy
6.2.2 Hemophilia
6.2.3 Retinal Diseases
6.2.4 Other
6.3 Market Segment by Application
6.3.1 World AAV Vector Gene Therapy Production by Application (2018-2029)
6.3.2 World AAV Vector Gene Therapy Production Value by Application (2018-2029)
6.3.3 World AAV Vector Gene Therapy Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 uniQure
7.1.1 uniQure Details
7.1.2 uniQure Major Business
7.1.3 uniQure AAV Vector Gene Therapy Product and Services
7.1.4 uniQure AAV Vector Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 uniQure Recent Developments/Updates
7.1.6 uniQure Competitive Strengths & Weaknesses
7.2 Roche
7.2.1 Roche Details
7.2.2 Roche Major Business
7.2.3 Roche AAV Vector Gene Therapy Product and Services
7.2.4 Roche AAV Vector Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Roche Recent Developments/Updates
7.2.6 Roche Competitive Strengths & Weaknesses
7.3 Novartis
7.3.1 Novartis Details
7.3.2 Novartis Major Business
7.3.3 Novartis AAV Vector Gene Therapy Product and Services
7.3.4 Novartis AAV Vector Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Novartis Recent Developments/Updates
7.3.6 Novartis Competitive Strengths & Weaknesses
7.4 BioMarin Pharmaceutical
7.4.1 BioMarin Pharmaceutical Details
7.4.2 BioMarin Pharmaceutical Major Business
7.4.3 BioMarin Pharmaceutical AAV Vector Gene Therapy Product and Services
7.4.4 BioMarin Pharmaceutical AAV Vector Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 BioMarin Pharmaceutical Recent Developments/Updates
7.4.6 BioMarin Pharmaceutical Competitive Strengths & Weaknesses
7.5 Ferring Pharmaceuticals A/S
7.5.1 Ferring Pharmaceuticals A/S Details
7.5.2 Ferring Pharmaceuticals A/S Major Business
7.5.3 Ferring Pharmaceuticals A/S AAV Vector Gene Therapy Product and Services
7.5.4 Ferring Pharmaceuticals A/S AAV Vector Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Ferring Pharmaceuticals A/S Recent Developments/Updates
7.5.6 Ferring Pharmaceuticals A/S Competitive Strengths & Weaknesses
7.6 CSL Behring LLC
7.6.1 CSL Behring LLC Details
7.6.2 CSL Behring LLC Major Business
7.6.3 CSL Behring LLC AAV Vector Gene Therapy Product and Services
7.6.4 CSL Behring LLC AAV Vector Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 CSL Behring LLC Recent Developments/Updates
7.6.6 CSL Behring LLC Competitive Strengths & Weaknesses
7.7 PTC Therapeutics, Inc.
7.7.1 PTC Therapeutics, Inc. Details
7.7.2 PTC Therapeutics, Inc. Major Business
7.7.3 PTC Therapeutics, Inc. AAV Vector Gene Therapy Product and Services
7.7.4 PTC Therapeutics, Inc. AAV Vector Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 PTC Therapeutics, Inc. Recent Developments/Updates
7.7.6 PTC Therapeutics, Inc. Competitive Strengths & Weaknesses
7.8 Pfizer Inc.
7.8.1 Pfizer Inc. Details
7.8.2 Pfizer Inc. Major Business
7.8.3 Pfizer Inc. AAV Vector Gene Therapy Product and Services
7.8.4 Pfizer Inc. AAV Vector Gene Therapy Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Pfizer Inc. Recent Developments/Updates
7.8.6 Pfizer Inc. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 AAV Vector Gene Therapy Industry Chain
8.2 AAV Vector Gene Therapy Upstream Analysis
8.2.1 AAV Vector Gene Therapy Core Raw Materials
8.2.2 Main Manufacturers of AAV Vector Gene Therapy Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 AAV Vector Gene Therapy Production Mode
8.6 AAV Vector Gene Therapy Procurement Model
8.7 AAV Vector Gene Therapy Industry Sales Model and Sales Channels
8.7.1 AAV Vector Gene Therapy Sales Model
8.7.2 AAV Vector Gene Therapy Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World AAV Vector Gene Therapy Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World AAV Vector Gene Therapy Production Value by Region (2018-2023) & (USD Million)
Table 3. World AAV Vector Gene Therapy Production Value by Region (2024-2029) & (USD Million)
Table 4. World AAV Vector Gene Therapy Production Value Market Share by Region (2018-2023)
Table 5. World AAV Vector Gene Therapy Production Value Market Share by Region (2024-2029)
Table 6. World AAV Vector Gene Therapy Production by Region (2018-2023) & (K Units)
Table 7. World AAV Vector Gene Therapy Production by Region (2024-2029) & (K Units)
Table 8. World AAV Vector Gene Therapy Production Market Share by Region (2018-2023)
Table 9. World AAV Vector Gene Therapy Production Market Share by Region (2024-2029)
Table 10. World AAV Vector Gene Therapy Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World AAV Vector Gene Therapy Average Price by Region (2024-2029) & (US$/Unit)
Table 12. AAV Vector Gene Therapy Major Market Trends
Table 13. World AAV Vector Gene Therapy Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World AAV Vector Gene Therapy Consumption by Region (2018-2023) & (K Units)
Table 15. World AAV Vector Gene Therapy Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World AAV Vector Gene Therapy Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key AAV Vector Gene Therapy Producers in 2022
Table 18. World AAV Vector Gene Therapy Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key AAV Vector Gene Therapy Producers in 2022
Table 20. World AAV Vector Gene Therapy Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global AAV Vector Gene Therapy Company Evaluation Quadrant
Table 22. World AAV Vector Gene Therapy Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and AAV Vector Gene Therapy Production Site of Key Manufacturer
Table 24. AAV Vector Gene Therapy Market: Company Product Type Footprint
Table 25. AAV Vector Gene Therapy Market: Company Product Application Footprint
Table 26. AAV Vector Gene Therapy Competitive Factors
Table 27. AAV Vector Gene Therapy New Entrant and Capacity Expansion Plans
Table 28. AAV Vector Gene Therapy Mergers & Acquisitions Activity
Table 29. United States VS China AAV Vector Gene Therapy Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China AAV Vector Gene Therapy Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China AAV Vector Gene Therapy Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based AAV Vector Gene Therapy Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers AAV Vector Gene Therapy Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers AAV Vector Gene Therapy Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers AAV Vector Gene Therapy Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers AAV Vector Gene Therapy Production Market Share (2018-2023)
Table 37. China Based AAV Vector Gene Therapy Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers AAV Vector Gene Therapy Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers AAV Vector Gene Therapy Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers AAV Vector Gene Therapy Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers AAV Vector Gene Therapy Production Market Share (2018-2023)
Table 42. Rest of World Based AAV Vector Gene Therapy Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers AAV Vector Gene Therapy Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers AAV Vector Gene Therapy Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers AAV Vector Gene Therapy Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers AAV Vector Gene Therapy Production Market Share (2018-2023)
Table 47. World AAV Vector Gene Therapy Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World AAV Vector Gene Therapy Production by Type (2018-2023) & (K Units)
Table 49. World AAV Vector Gene Therapy Production by Type (2024-2029) & (K Units)
Table 50. World AAV Vector Gene Therapy Production Value by Type (2018-2023) & (USD Million)
Table 51. World AAV Vector Gene Therapy Production Value by Type (2024-2029) & (USD Million)
Table 52. World AAV Vector Gene Therapy Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World AAV Vector Gene Therapy Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World AAV Vector Gene Therapy Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World AAV Vector Gene Therapy Production by Application (2018-2023) & (K Units)
Table 56. World AAV Vector Gene Therapy Production by Application (2024-2029) & (K Units)
Table 57. World AAV Vector Gene Therapy Production Value by Application (2018-2023) & (USD Million)
Table 58. World AAV Vector Gene Therapy Production Value by Application (2024-2029) & (USD Million)
Table 59. World AAV Vector Gene Therapy Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World AAV Vector Gene Therapy Average Price by Application (2024-2029) & (US$/Unit)
Table 61. uniQure Basic Information, Manufacturing Base and Competitors
Table 62. uniQure Major Business
Table 63. uniQure AAV Vector Gene Therapy Product and Services
Table 64. uniQure AAV Vector Gene Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. uniQure Recent Developments/Updates
Table 66. uniQure Competitive Strengths & Weaknesses
Table 67. Roche Basic Information, Manufacturing Base and Competitors
Table 68. Roche Major Business
Table 69. Roche AAV Vector Gene Therapy Product and Services
Table 70. Roche AAV Vector Gene Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Roche Recent Developments/Updates
Table 72. Roche Competitive Strengths & Weaknesses
Table 73. Novartis Basic Information, Manufacturing Base and Competitors
Table 74. Novartis Major Business
Table 75. Novartis AAV Vector Gene Therapy Product and Services
Table 76. Novartis AAV Vector Gene Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Novartis Recent Developments/Updates
Table 78. Novartis Competitive Strengths & Weaknesses
Table 79. BioMarin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 80. BioMarin Pharmaceutical Major Business
Table 81. BioMarin Pharmaceutical AAV Vector Gene Therapy Product and Services
Table 82. BioMarin Pharmaceutical AAV Vector Gene Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. BioMarin Pharmaceutical Recent Developments/Updates
Table 84. BioMarin Pharmaceutical Competitive Strengths & Weaknesses
Table 85. Ferring Pharmaceuticals A/S Basic Information, Manufacturing Base and Competitors
Table 86. Ferring Pharmaceuticals A/S Major Business
Table 87. Ferring Pharmaceuticals A/S AAV Vector Gene Therapy Product and Services
Table 88. Ferring Pharmaceuticals A/S AAV Vector Gene Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Ferring Pharmaceuticals A/S Recent Developments/Updates
Table 90. Ferring Pharmaceuticals A/S Competitive Strengths & Weaknesses
Table 91. CSL Behring LLC Basic Information, Manufacturing Base and Competitors
Table 92. CSL Behring LLC Major Business
Table 93. CSL Behring LLC AAV Vector Gene Therapy Product and Services
Table 94. CSL Behring LLC AAV Vector Gene Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. CSL Behring LLC Recent Developments/Updates
Table 96. CSL Behring LLC Competitive Strengths & Weaknesses
Table 97. PTC Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors
Table 98. PTC Therapeutics, Inc. Major Business
Table 99. PTC Therapeutics, Inc. AAV Vector Gene Therapy Product and Services
Table 100. PTC Therapeutics, Inc. AAV Vector Gene Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. PTC Therapeutics, Inc. Recent Developments/Updates
Table 102. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 103. Pfizer Inc. Major Business
Table 104. Pfizer Inc. AAV Vector Gene Therapy Product and Services
Table 105. Pfizer Inc. AAV Vector Gene Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 106. Global Key Players of AAV Vector Gene Therapy Upstream (Raw Materials)
Table 107. AAV Vector Gene Therapy Typical Customers
Table 108. AAV Vector Gene Therapy Typical Distributors
LIST OF FIGURE
Figure 1. AAV Vector Gene Therapy Picture
Figure 2. World AAV Vector Gene Therapy Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World AAV Vector Gene Therapy Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World AAV Vector Gene Therapy Production (2018-2029) & (K Units)
Figure 5. World AAV Vector Gene Therapy Average Price (2018-2029) & (US$/Unit)
Figure 6. World AAV Vector Gene Therapy Production Value Market Share by Region (2018-2029)
Figure 7. World AAV Vector Gene Therapy Production Market Share by Region (2018-2029)
Figure 8. North America AAV Vector Gene Therapy Production (2018-2029) & (K Units)
Figure 9. Europe AAV Vector Gene Therapy Production (2018-2029) & (K Units)
Figure 10. China AAV Vector Gene Therapy Production (2018-2029) & (K Units)
Figure 11. Japan AAV Vector Gene Therapy Production (2018-2029) & (K Units)
Figure 12. AAV Vector Gene Therapy Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World AAV Vector Gene Therapy Consumption (2018-2029) & (K Units)
Figure 15. World AAV Vector Gene Therapy Consumption Market Share by Region (2018-2029)
Figure 16. United States AAV Vector Gene Therapy Consumption (2018-2029) & (K Units)
Figure 17. China AAV Vector Gene Therapy Consumption (2018-2029) & (K Units)
Figure 18. Europe AAV Vector Gene Therapy Consumption (2018-2029) & (K Units)
Figure 19. Japan AAV Vector Gene Therapy Consumption (2018-2029) & (K Units)
Figure 20. South Korea AAV Vector Gene Therapy Consumption (2018-2029) & (K Units)
Figure 21. ASEAN AAV Vector Gene Therapy Consumption (2018-2029) & (K Units)
Figure 22. India AAV Vector Gene Therapy Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of AAV Vector Gene Therapy by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for AAV Vector Gene Therapy Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for AAV Vector Gene Therapy Markets in 2022
Figure 26. United States VS China: AAV Vector Gene Therapy Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: AAV Vector Gene Therapy Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: AAV Vector Gene Therapy Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers AAV Vector Gene Therapy Production Market Share 2022
Figure 30. China Based Manufacturers AAV Vector Gene Therapy Production Market Share 2022
Figure 31. Rest of World Based Manufacturers AAV Vector Gene Therapy Production Market Share 2022
Figure 32. World AAV Vector Gene Therapy Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World AAV Vector Gene Therapy Production Value Market Share by Type in 2022
Figure 34. AAV1
Figure 35. AAV2
Figure 36. AAV8
Figure 37. Other
Figure 38. World AAV Vector Gene Therapy Production Market Share by Type (2018-2029)
Figure 39. World AAV Vector Gene Therapy Production Value Market Share by Type (2018-2029)
Figure 40. World AAV Vector Gene Therapy Average Price by Type (2018-2029) & (US$/Unit)
Figure 41. World AAV Vector Gene Therapy Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 42. World AAV Vector Gene Therapy Production Value Market Share by Application in 2022
Figure 43. Duchenne Dystrophy
Figure 44. Hemophilia
Figure 45. Retinal Diseases
Figure 46. Other
Figure 47. World AAV Vector Gene Therapy Production Market Share by Application (2018-2029)
Figure 48. World AAV Vector Gene Therapy Production Value Market Share by Application (2018-2029)
Figure 49. World AAV Vector Gene Therapy Average Price by Application (2018-2029) & (US$/Unit)
Figure 50. AAV Vector Gene Therapy Industry Chain
Figure 51. AAV Vector Gene Therapy Procurement Model
Figure 52. AAV Vector Gene Therapy Sales Model
Figure 53. AAV Vector Gene Therapy Sales Channels, Direct Sales, and Distribution
Figure 54. Methodology
Figure 55. Research Process and Data Source
Table 1. World AAV Vector Gene Therapy Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World AAV Vector Gene Therapy Production Value by Region (2018-2023) & (USD Million)
Table 3. World AAV Vector Gene Therapy Production Value by Region (2024-2029) & (USD Million)
Table 4. World AAV Vector Gene Therapy Production Value Market Share by Region (2018-2023)
Table 5. World AAV Vector Gene Therapy Production Value Market Share by Region (2024-2029)
Table 6. World AAV Vector Gene Therapy Production by Region (2018-2023) & (K Units)
Table 7. World AAV Vector Gene Therapy Production by Region (2024-2029) & (K Units)
Table 8. World AAV Vector Gene Therapy Production Market Share by Region (2018-2023)
Table 9. World AAV Vector Gene Therapy Production Market Share by Region (2024-2029)
Table 10. World AAV Vector Gene Therapy Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World AAV Vector Gene Therapy Average Price by Region (2024-2029) & (US$/Unit)
Table 12. AAV Vector Gene Therapy Major Market Trends
Table 13. World AAV Vector Gene Therapy Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World AAV Vector Gene Therapy Consumption by Region (2018-2023) & (K Units)
Table 15. World AAV Vector Gene Therapy Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World AAV Vector Gene Therapy Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key AAV Vector Gene Therapy Producers in 2022
Table 18. World AAV Vector Gene Therapy Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key AAV Vector Gene Therapy Producers in 2022
Table 20. World AAV Vector Gene Therapy Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global AAV Vector Gene Therapy Company Evaluation Quadrant
Table 22. World AAV Vector Gene Therapy Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and AAV Vector Gene Therapy Production Site of Key Manufacturer
Table 24. AAV Vector Gene Therapy Market: Company Product Type Footprint
Table 25. AAV Vector Gene Therapy Market: Company Product Application Footprint
Table 26. AAV Vector Gene Therapy Competitive Factors
Table 27. AAV Vector Gene Therapy New Entrant and Capacity Expansion Plans
Table 28. AAV Vector Gene Therapy Mergers & Acquisitions Activity
Table 29. United States VS China AAV Vector Gene Therapy Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China AAV Vector Gene Therapy Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China AAV Vector Gene Therapy Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based AAV Vector Gene Therapy Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers AAV Vector Gene Therapy Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers AAV Vector Gene Therapy Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers AAV Vector Gene Therapy Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers AAV Vector Gene Therapy Production Market Share (2018-2023)
Table 37. China Based AAV Vector Gene Therapy Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers AAV Vector Gene Therapy Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers AAV Vector Gene Therapy Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers AAV Vector Gene Therapy Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers AAV Vector Gene Therapy Production Market Share (2018-2023)
Table 42. Rest of World Based AAV Vector Gene Therapy Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers AAV Vector Gene Therapy Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers AAV Vector Gene Therapy Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers AAV Vector Gene Therapy Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers AAV Vector Gene Therapy Production Market Share (2018-2023)
Table 47. World AAV Vector Gene Therapy Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World AAV Vector Gene Therapy Production by Type (2018-2023) & (K Units)
Table 49. World AAV Vector Gene Therapy Production by Type (2024-2029) & (K Units)
Table 50. World AAV Vector Gene Therapy Production Value by Type (2018-2023) & (USD Million)
Table 51. World AAV Vector Gene Therapy Production Value by Type (2024-2029) & (USD Million)
Table 52. World AAV Vector Gene Therapy Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World AAV Vector Gene Therapy Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World AAV Vector Gene Therapy Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World AAV Vector Gene Therapy Production by Application (2018-2023) & (K Units)
Table 56. World AAV Vector Gene Therapy Production by Application (2024-2029) & (K Units)
Table 57. World AAV Vector Gene Therapy Production Value by Application (2018-2023) & (USD Million)
Table 58. World AAV Vector Gene Therapy Production Value by Application (2024-2029) & (USD Million)
Table 59. World AAV Vector Gene Therapy Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World AAV Vector Gene Therapy Average Price by Application (2024-2029) & (US$/Unit)
Table 61. uniQure Basic Information, Manufacturing Base and Competitors
Table 62. uniQure Major Business
Table 63. uniQure AAV Vector Gene Therapy Product and Services
Table 64. uniQure AAV Vector Gene Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. uniQure Recent Developments/Updates
Table 66. uniQure Competitive Strengths & Weaknesses
Table 67. Roche Basic Information, Manufacturing Base and Competitors
Table 68. Roche Major Business
Table 69. Roche AAV Vector Gene Therapy Product and Services
Table 70. Roche AAV Vector Gene Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Roche Recent Developments/Updates
Table 72. Roche Competitive Strengths & Weaknesses
Table 73. Novartis Basic Information, Manufacturing Base and Competitors
Table 74. Novartis Major Business
Table 75. Novartis AAV Vector Gene Therapy Product and Services
Table 76. Novartis AAV Vector Gene Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Novartis Recent Developments/Updates
Table 78. Novartis Competitive Strengths & Weaknesses
Table 79. BioMarin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 80. BioMarin Pharmaceutical Major Business
Table 81. BioMarin Pharmaceutical AAV Vector Gene Therapy Product and Services
Table 82. BioMarin Pharmaceutical AAV Vector Gene Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. BioMarin Pharmaceutical Recent Developments/Updates
Table 84. BioMarin Pharmaceutical Competitive Strengths & Weaknesses
Table 85. Ferring Pharmaceuticals A/S Basic Information, Manufacturing Base and Competitors
Table 86. Ferring Pharmaceuticals A/S Major Business
Table 87. Ferring Pharmaceuticals A/S AAV Vector Gene Therapy Product and Services
Table 88. Ferring Pharmaceuticals A/S AAV Vector Gene Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Ferring Pharmaceuticals A/S Recent Developments/Updates
Table 90. Ferring Pharmaceuticals A/S Competitive Strengths & Weaknesses
Table 91. CSL Behring LLC Basic Information, Manufacturing Base and Competitors
Table 92. CSL Behring LLC Major Business
Table 93. CSL Behring LLC AAV Vector Gene Therapy Product and Services
Table 94. CSL Behring LLC AAV Vector Gene Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. CSL Behring LLC Recent Developments/Updates
Table 96. CSL Behring LLC Competitive Strengths & Weaknesses
Table 97. PTC Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors
Table 98. PTC Therapeutics, Inc. Major Business
Table 99. PTC Therapeutics, Inc. AAV Vector Gene Therapy Product and Services
Table 100. PTC Therapeutics, Inc. AAV Vector Gene Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. PTC Therapeutics, Inc. Recent Developments/Updates
Table 102. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 103. Pfizer Inc. Major Business
Table 104. Pfizer Inc. AAV Vector Gene Therapy Product and Services
Table 105. Pfizer Inc. AAV Vector Gene Therapy Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 106. Global Key Players of AAV Vector Gene Therapy Upstream (Raw Materials)
Table 107. AAV Vector Gene Therapy Typical Customers
Table 108. AAV Vector Gene Therapy Typical Distributors
LIST OF FIGURE
Figure 1. AAV Vector Gene Therapy Picture
Figure 2. World AAV Vector Gene Therapy Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World AAV Vector Gene Therapy Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World AAV Vector Gene Therapy Production (2018-2029) & (K Units)
Figure 5. World AAV Vector Gene Therapy Average Price (2018-2029) & (US$/Unit)
Figure 6. World AAV Vector Gene Therapy Production Value Market Share by Region (2018-2029)
Figure 7. World AAV Vector Gene Therapy Production Market Share by Region (2018-2029)
Figure 8. North America AAV Vector Gene Therapy Production (2018-2029) & (K Units)
Figure 9. Europe AAV Vector Gene Therapy Production (2018-2029) & (K Units)
Figure 10. China AAV Vector Gene Therapy Production (2018-2029) & (K Units)
Figure 11. Japan AAV Vector Gene Therapy Production (2018-2029) & (K Units)
Figure 12. AAV Vector Gene Therapy Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World AAV Vector Gene Therapy Consumption (2018-2029) & (K Units)
Figure 15. World AAV Vector Gene Therapy Consumption Market Share by Region (2018-2029)
Figure 16. United States AAV Vector Gene Therapy Consumption (2018-2029) & (K Units)
Figure 17. China AAV Vector Gene Therapy Consumption (2018-2029) & (K Units)
Figure 18. Europe AAV Vector Gene Therapy Consumption (2018-2029) & (K Units)
Figure 19. Japan AAV Vector Gene Therapy Consumption (2018-2029) & (K Units)
Figure 20. South Korea AAV Vector Gene Therapy Consumption (2018-2029) & (K Units)
Figure 21. ASEAN AAV Vector Gene Therapy Consumption (2018-2029) & (K Units)
Figure 22. India AAV Vector Gene Therapy Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of AAV Vector Gene Therapy by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for AAV Vector Gene Therapy Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for AAV Vector Gene Therapy Markets in 2022
Figure 26. United States VS China: AAV Vector Gene Therapy Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: AAV Vector Gene Therapy Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: AAV Vector Gene Therapy Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers AAV Vector Gene Therapy Production Market Share 2022
Figure 30. China Based Manufacturers AAV Vector Gene Therapy Production Market Share 2022
Figure 31. Rest of World Based Manufacturers AAV Vector Gene Therapy Production Market Share 2022
Figure 32. World AAV Vector Gene Therapy Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World AAV Vector Gene Therapy Production Value Market Share by Type in 2022
Figure 34. AAV1
Figure 35. AAV2
Figure 36. AAV8
Figure 37. Other
Figure 38. World AAV Vector Gene Therapy Production Market Share by Type (2018-2029)
Figure 39. World AAV Vector Gene Therapy Production Value Market Share by Type (2018-2029)
Figure 40. World AAV Vector Gene Therapy Average Price by Type (2018-2029) & (US$/Unit)
Figure 41. World AAV Vector Gene Therapy Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 42. World AAV Vector Gene Therapy Production Value Market Share by Application in 2022
Figure 43. Duchenne Dystrophy
Figure 44. Hemophilia
Figure 45. Retinal Diseases
Figure 46. Other
Figure 47. World AAV Vector Gene Therapy Production Market Share by Application (2018-2029)
Figure 48. World AAV Vector Gene Therapy Production Value Market Share by Application (2018-2029)
Figure 49. World AAV Vector Gene Therapy Average Price by Application (2018-2029) & (US$/Unit)
Figure 50. AAV Vector Gene Therapy Industry Chain
Figure 51. AAV Vector Gene Therapy Procurement Model
Figure 52. AAV Vector Gene Therapy Sales Model
Figure 53. AAV Vector Gene Therapy Sales Channels, Direct Sales, and Distribution
Figure 54. Methodology
Figure 55. Research Process and Data Source
